Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.900
-0.020 (-0.41%)
At close: Mar 13, 2026, 4:00 PM EDT
4.920
+0.020 (0.41%)
After-hours: Mar 13, 2026, 6:17 PM EDT
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Foghorn Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 134.69% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $13.
Price Target: $11.5 (+134.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 3 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +104.08% | Mar 12, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +165.31% | Mar 10, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +144.90% | Feb 17, 2026 |
| BTIG | BTIG | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +124.49% | Dec 18, 2025 |
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +144.90% | Dec 4, 2025 |
Financial Forecast
Revenue This Year
35.43M
from 30.91M
Increased by 14.62%
Revenue Next Year
40.84M
from 35.43M
Increased by 15.27%
EPS This Year
-1.07
from -1.18
EPS Next Year
-1.12
from -1.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 63.0M | 64.3M | |||
| Avg | 35.4M | 40.8M | |||
| Low | n/a | 19.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 103.8% | 81.4% | |||
| Avg | 14.6% | 15.3% | |||
| Low | - | -44.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.74 | -0.74 | |||
| Avg | -1.07 | -1.12 | |||
| Low | -1.51 | -1.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.